Hong JH, Kim MJ, Min KW, Won JC, et al. Efficacy and safety of a fixed-dose combination of dapagliflozin and linagliptin (AJU-A51) in patients with type 2 diabetes mellitus: A multicentre, randomized, double-blind, parallel-group, placebo-controlled phase III study. Diabetes Obes Metab 2024 Oct 7. doi: 10.1111/dom.15985.
PMID: 39375869